Opioid prescribing

 

Morphine remains the first line oral opioid of choice.

         

·        If regular weak opioid is not controlling pain, initiate sustained release morphine (MST) 10-15mg bd

·        At the same time prescribe ‘as required’ oral morphine sulphate solution (immediate release morphine) 2.5-5mg

·        Review after 24-48 hours, add up total daily dose of morphine given. Divide by two and prescribe this     

    new dose as MST (sustained release morphine) twice daily

·        At the same time increase dose of immediate release oral morphine solution to one sixth of the total daily dose

 

Example:

Patient commenced 2 days ago on MST 15mg bd.

Over previous 24 hours he has used 6 extra doses of morphine sulphate solution 5mg for breakthrough pain

Total morphine dose in 24 hours = 15mg MST+ 15mg MST + (6X 5mg morphine sulphate solution) = 60mg

 

New dose MST is 60mg divided by 2 = 30mg bd

New dose morphine sulphate solution is 60mg divided by 6 = 10mg

 

·        At the same time initiate regular softener-stimulant laxative (e.g. codanthramer  capsules or  solution at night )

·        If nausea develops as a result of commencing morphine use regular haloperidol 1.5 mg od orally or sub-cutaneously. You may be able to stop this after 5 days.

Review

·          Pain needs ongoing review.

·          Opioid dosage may need increasing by a third if patient is continuing to experience pain and the pain is opioid sensitive.

·          Alternatively summate doses required for breakthrough pain and increase the regular dose accordingly as described previously.

·          Laxatives may need to be increased with the increased morphine dose

·          Increased drowsiness and pin point pupils may be an indication that the dose of opioid is too high and requires reduction

 

Oxycodone is the second line oral opioid of choice.

·        A small proportion of patients are intolerant to morphine i.e. if they experience profound drowsiness or cognitive side effects.  In these situations alternative opioids can be considered. 

·         The preferred second line opioid is oxycodone.

·         Oxycontin is the 12 hourly sustained release formulation, oxynorm is the immediate release preparation

 

Transdermal fentanyl may be appropriate for certain circumstances

·       Fentanyl patches can be useful if patient’s pain is well controlled with morphine and patients are struggling to    swallow or there are problems with compliance. However, uncontrolled pain is difficult to manage with fentanyl due to its long half life.

·         Care is needed with potency, fentanyl 25mcg/hr is equivalent to 60-90mg morphine/24hrs. Toxicity can occur and a reservoir of fentanyl accumulates under the skin so that significant blood levels can persist for 24 hours after removal of the patch.

 

Approximate relative potencies of oral morphine, oral oxycodone, transdermal fentanyl and subcutaneous diamorphine

 

4 hrly

oral morphine (mg)

24 hrly                          

oral morphine (mg)    

24 hrly

oral oxycodone (mg)

Fentanyl Patch (mcg/hr)

24 hrly SC diamorphine (mg) 

 or 24 hrly SC oxycodone (mg)

10-20

 

60-120

           30 - 60

25

20-40

25-35

 

150-210

           75 - 105

50

50-70

40-50

 

240-300

         120 - 150

75

80-100

55-65

 

330-390

         165 - 195

100

110-130

 

 

Opioids via syringe driver

 

To convert oral morphine to SC diamorphine

·         3 mg oral morphine equivalent to l mg diamorphine SC

·         Prescribe additional single doses of SC diamorphine ‘as required’ for breakthrough pain, equivalent to one-sixth of 24 hr syringe pump dose  

   

 

If diamorphine is not available:

 

Oxycodone can be used – the dose is the same as that for diamorphine

 

Morphine can be used – the dose in the syringe driver over 24 hours is half the oral dose over 24 hours. 

 

 

 

 

If not nauseated on regular oral opioids an antiemetic  is unnecessary when converting to SC infusion